Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program | Zendy

Benjamin Eckhardt | Zendy; Matthew Scherer | Zendy; Emily Winkelstein | Zendy; Kristen Marks | Zendy; Brian R. Edlin | Zendy

Open Access

Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program

Author(s) -

Benjamin Eckhardt,

Matthew Scherer,

Emily Winkelstein,

Kristen Marks,

Brian R. Edlin

Publication year - 2018

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofy048

Subject(s) - medicine , syringe , hepatitis c , hepatitis c virus , family medicine , human immunodeficiency virus (hiv) , hepatitis , service (business) , virology , intensive care medicine , virus , psychiatry , economy , economics

Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research